In addition, immune analysis, including various bioinformatics tools, revealed significant differences in the tumor microenvironment and immune cell infiltration between the low-risk and high-risk groups, particularly the immune checkpoints PD-1, CTLA-4, and TIM3. The gene discussed is HAVCR2; the disease is neoplasm.